Depression and anxiety disorders during the COVID-19 pandemic: knowns and unknowns

Maxime Taquet(Oxford Health NHS Foundation Trust), Paul J. Harrison(King's College London), Emily A. Holmes(Uppsala University)

The Lancet

October 9, 2021

10.1016/s0140-6736(21)02221-2

Cited by 101

Related Papers

Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science

|The Lancet Psychiatry|2020|6k

6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records

|The Lancet Psychiatry|2021|2.2k

Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA

|The Lancet Psychiatry|2020|1.5k

Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19

|PLoS Medicine|2021|983

Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients

|The Lancet Psychiatry|2022|722